advertisement
Eye 15
Showing records 1 to 15 | Display all abstracts in Eye11312 Functions of optic nerve glia: axoglial signalling in physiology and pathology
Butt AM; Pugh M; Hubbard P; James G
Eye 2004; 18: 1110-1121
11328 Circulation and axonal transport in the optic nerve
Morgan JE
Eye 2004; 18: 1089-1095
11386 Stem cells to replace the optic nerve
Quigley HA; Iglesia DS
Eye 2004; 18: 1085-1088
11327 A history of the optic nerve and its diseases
Reeves C; Taylor D
Eye 2004; 18: 1096-1109
11313 Image analysis of optic nerve disease
Burgoyne CF
Eye 2004; 18: 1207-1213
11308 A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients
Tomita G; Araie M; Kitazawa Y; Tsukahara S
Eye 2004; 18: 984-989
11355 Congenital disorders of the optic nerve: excavations and hypoplasia
Dutton GN
Eye 2004; 18: 1038-1048
11320 Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management
Hayreh SS
Eye 2004; 18: 1188-1206
11309 Reducing intraocular pressure: is surgery better than drugs?
Shaarawy T; Flammer J; Haefliger IO
Eye 2004; 18: 1215-1224
11307 Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy
Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
Eye 2004; 18: 990-995
11300 Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%
Konstas AGP; Kozobolis VP; Lallos N; Christodoulakis E; Stewart JA; Stewart WC
Eye 2004; 18: 1264-1269
11228 Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma
Konstas AGP; Mylopoulos N; Karabatsas CH; Kozobolis VP; Diafas S; Papapanos P; Georgiadis N; Stewart WC
Eye 2004; 18: 893-899
11505 Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects
Stewart WC; Day DG; Stewart JA; Holmes KT; Jenkins JN
Eye 2004; 18: 905-910
11360 Optic nerve and neuroprotection strategies
Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
Eye 2004; 18: 1075-1084
11389 Gene therapy for optic nerve disease
Martin KR; Quigley HA
Eye 2004; 18: 1049-1055
